ADIPONEXIN

Serial Number 75142191
606

Registration Progress

Application Filed
Jul 30, 1996
Under Examination
Aug 26, 1997
Approved for Publication
May 2, 1997
Published for Opposition
Jun 3, 1997
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ADIPONEXIN
Previous Owner: OSIRIS THERAPEUTICS, INC.
Classes: 005

Trademark Image

ADIPONEXIN

Basic Information

Serial Number
75142191
Filing Date
July 30, 1996
Published for Opposition
June 3, 1997
Abandonment Date
February 27, 2000
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 27, 2000
Classes
005

Rights Holder

OSIRIS THERAPEUTICS, INC.

03
Address
2001 Aliceanna Street
Baltimore, MD 21231

Ownership History

OSIRIS THERAPEUTICS, INC.

Original Applicant
03
Baltimore, MD

OSIRIS THERAPEUTICS, INC.

Owner at Publication
03
Baltimore, MD

Legal Representation

Attorney
William Squire

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

15 events
Date Code Type Description Documents
Jun 29, 2000 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 20, 1999 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 21, 1999 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 23, 1999 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 4, 1999 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 22, 1998 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 2, 1998 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 2, 1998 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 15, 1998 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 26, 1997 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 3, 1997 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 2, 1997 NPUB O NOTICE OF PUBLICATION Loading...
Jan 18, 1997 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 14, 1997 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Jan 9, 1997 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
chemical or biological agents which cause tissue-forming progenitor cells to commit into or produce differentiated adipose tissue in vitro or in vivo for medical use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005